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Incidence and Predictive Factors of Benign Renal Lesions in 
Korean Patients with Preoperative Imaging Diagnoses of Renal 
Cell Carcinoma 
The present study was performed to determine the incidence and predictive factors of 
benign renal lesions in Korean patients undergoing nephrectomy for presumed renal cell 
carcinoma on preoperative imaging. We analyzed the pathologic reports and medical 
records of 1,598 eligible patients with unilateral, nonmetastatic, and nonfamilial renal 
masses. Of the 1,598 renal masses, 114 (7.1%) were benign lesions, including 
angiomyolipoma in 47 (2.9%), oncocytoma in 23 (1.4%), and complicated cysts in 18 
(1.1%) patients. On univariate analysis, the proportion of benign lesions was significantly 
higher in female patients, and in patients with smaller tumors, cystic renal masses, and 
without gross hematuria as a presenting symptom. When renal lesions were stratified by 
tumor size, the proportion of benign as opposed to malignant lesions decreased significantly 
as tumor size increased. On multivariate analysis, female gender, smaller tumor size, and 
cystic lesions were significantly associated with benign histological features. The findings in 
this large cohort of Korean patients show a lower incidence (7.1%) of benign renal lesions 
than those of previous Western reports. Female gender, cystic renal lesions, and smaller 
tumor size are independent predictors of benign histological features. 
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INTRODUCTION
Advances in modern imaging technology and the widespread 
implementation of conventional imaging modalities, such as 
ultrasonography (USG), computed tomography (CT), and mag-
netic resonance imaging (MRI), have led to an increase in the 
detection of incidental renal neoplasms (1, 2). Consequently, 
the incidence of benign renal masses has increased along with 
the increasing incidence of renal cell carcinoma (RCC) because 
current imaging and biopsy techniques cannot predict the his-
tological features of renal tumors with complete accuracy (1, 3, 
4). In contemporary practice, a number of Western studies have 
reported a 13%-25% incidence of benign renal lesions at nephrec-
tomy (3, 5-11), although data on Asian patients are scarce. The 
few studies conducted with patients in Asian countries have re-
ported a lower incidence, 10%-11%, than that reported by West-
ern studies (12, 13). However, these studies were limited in that 
the data were based on relatively small study cohorts, and most 
studies excluded large masses. 
  The objectives of this study were to determine the incidence 
of benign renal lesions in a large cohort of Korean patients un-
dergoing nephrectomies for image diagnosis of RCC and to in-
vestigate the clinical predictors of benign renal tumors.
MATERIALS AND METHODS
The institutional review board at our institution approved this 
study. A total of 2,269 patients underwent nephrectomies be-
tween January 2000 and May 2010. We excluded 451 patients 
whose operations were recorded as simple nephrectomy, and 
220 patients with recurred renal cancer, bilateral disease, meta-
static disease, or familial disease. Hence, the medical records of 
1,598 eligible patients who underwent consecutive radical or 
partial nephrectomies for presumed RCC were retrospectively 
reviewed and analyzed. In the 23 patients with multiple tumors 
in the same kidney, the largest tumor was included in the anal-
ysis. All patients underwent preoperative contrast-enhanced 
CT scans, MR imaging, or both for clinical diagnosis and stag-
ing, and all lesions included in this analysis were deemed suffi-
ciently suspicious for RCC on preoperative imaging. Since data 
were collected at a single tertiary referral center, many patients 
were transferred from primary or secondary care centers after 
initial CT imaging was conducted. Experienced genitourinary 
radiologists at our institution reviewed all imaging studies that 
were performed at outside hospitals. If an image was obscure 
or of poor quality, we performed an additional imaging study, 
such as CT, MRI, or contrast-enhanced renal USG. When the Park SY, et al.  •  Incidence and Predictive Factors of Benign Renal Lesions 
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results of additional imaging revealed a greater chance of a be-
nign lesion, the lesions were closely monitored in most cases. If 
we performed nephrectomies for such lesions, the operations 
were recorded as simple nephrectomies and the patients were 
excluded. Renal lesions were classified into the following three 
categories on the basis of the pathologic reports: benign lesion, 
RCC, or other malignancy. Cystic renal masses were classified 
using the Bosniak classification (14). Bosniak category III lesions 
were defined as indeterminate cystic masses with thickened ir-
regular walls or septa in which enhancement could be seen, and 
Bosniak category IV lesions were defined as clearly malignant 
cystic lesions that contained enhancing soft-tissue components. 
Renal carcinomas were classified according to the recommen-
dations of the 1997 American Joint Committee on Cancer report 
of RCC classification and the Heidelberg classification scheme 
(15, 16). Tumor size was determined using pathological mea-
surements. The data were analyzed as continuous variables and 
as categorical variables, stratifying tumors 2 cm or smaller, 2-4 
cm, 4-7 cm, or larger than 7 cm.
  Statistical analyses were performed with SPSS 17.0 software 
(SPSS, Chicago, IL, USA). Categorical variables were compared 
using the chi-square or Fisher’s exact test, and continuous vari-
ables were compared using the Mann-Whitney test with or with-
out Bonferroni’s correction. Logistic regression analysis was per-
formed to identify the variables predictive of benign lesions. All 
P values were two-sided, and differences were considered sta-
tistically significant at P < 0.05.
Ethics statement
This study protocol was approved by the institutional review 
board (IRB) of the Samsung Medical Center (No. 2010-11-026). 
With the approval of the IRB, this study was exempted from writ-
ten informed consent.
RESULTS
Table 1 summarizes the clinicopathological parameters that 
were assessed in this study. Among the 1,598 patients, 1,081 pa-
tients (67.6%) were male and 517 patients (32.4%) were female. 
The mean age was 54.3 yr (range, 10 to 86), and the mean tumor 
size was 4.8 cm (range, 0.6 to 24 cm). Of the 1,598 renal masses, 
1,468 (91.9%) were RCC and 16 (1.0%) were other malignancies. 
Benign renal lesions were found in 114 (7.1%) patients, including 
angiomyolipoma (AML) in 47 (2.9%), oncocytoma in 23 (1.4%), 
complicated cyst in 18 (1.1%), and metanephric adenoma in 6 
(0.4%) patients (Table 2). AML constituted 41.2% of all benign 
lesions; when a tumor was 4 cm or smaller, AML was the most 
common benign renal tumor, whereas oncocytoma was most 
prevalent if the tumor was larger than 4 cm (Table 2). The pro-
portion of benign lesions was significantly higher in females 
than in males (13.5% vs 4.1%, P < 0.001). The most common pre-
senting symptom was gross hematuria (9.4%), followed by ipsi-
lateral flank pain (8.0%), systemic symptoms including weight 
loss or severe fatigue (3.4%), and palpable abdominal masses 
(1.3%). Gross hematuria was significantly more common in pa-
tients with malignant lesions (P = 0.026). When renal lesions 
were stratified according to tumor size, the incidence of benign 
as opposed to malignant lesions decreased significantly as tu-
mor size increased (P = 0.004) (Table 1). In patients with renal 
masses 2 cm or smaller, 2-4 cm, 4-7 cm, and larger than 7.0 cm, 
the incidences of benign lesions were 11.7%, 7.5%, 6.1%, and 
Table 1. Clinicopathological characteristics of patients
Parameters
Total  
sample
Pathological findings P 
value Benign Malignant
No. of patients (%) 1,598 114 (7.1) 1,484 (92.9)  
Mean age (yr) (range) 54.3 (10-86) 53.4 (25-82) 54.4 (10-86) 0.459
Gender (%)
   Male
   Female
 
1,081 (67.6)
   517 (32.4)
 
    44 (38.6)
    70 (61.4)
 
1,037 (69.9)
   447 (30.1)
< 0.001
Presenting symptom (%)
   Gross hematuria
   Flank pain (ipsilateral side)
   Palpable mass
   Weight loss or severe  
      fatigue
 
 150 (9.4)
 128 (8.0)
   21 (1.3)
   54 (3.4)
 
    4 (3.5)
  11 (9.6)
    3 (2.6)
    4 (3.5)
 
 146 (9.8)
 117 (7.9)
   18 (1.2)
   50 (3.4)
 
0.026
0.503
0.185
0.546
Surgical method (%)
   Partial nephrectomy
   Radical nephrectomy
 
   386 (24.2)
1,212 (75.8)
 
    44 (38.6)
    70 (61.4)
 
   342 (23.0)
1,142 (77.0)
< 0.001
Nature of the lesion (%)
   Solid
   Cystic
 
1,466 (91.7)
 132 (8.3)
 
    96 (84.2)
    18 (15.8)
 
1,370 (92.3)
 114 (7.7)
 
0.002
 
Mean tumor size (cm)  
   (range)
4.8 (0.6-24) 3.9 (0.6-16) 4.9 (0.6-24) 0.001
Tumor size (cm) (%) 
   ≤ 2.0
   2-4
   4-7
   > 7.0
 
   274 (17.1)
   583 (36.5)
   445 (27.8)
   296 (18.5)
 
    32 (11.7)
  44 (7.5)
  27 (6.1)
  11 (3.7)
 
   242 (88.3)
   539 (92.5)
   418 (93.9)
   285 (96.3)
0.004
Table 2. Pathological findings of all renal lesions
Lesions
Number of pathological subtype (%)
≤ 4 cm  
(n = 857)
> 4 cm  
(n = 741)
Total  
(n = 1,598)
Benign
   Angiomyolipoma
   Oncocytoma
   Complicated cyst
   Metanephric adenoma
   Leiomyoma
   Xanthogranulomatous PN
   Cystic nephroma
   Others
76 (8.9)
37 (4.3)
11 (1.3)
13 (1.5)
 4 (0.5)
 3 (0.4)
 2 (0.2)
 1 (0.1)
 5 (0.6)
38 (5.1)
10 (1.3)
12 (1.6)
 5 (0.7)
 2 (0.3)
 1 (0.1)
 2 (0.3)
 3 (0.4)
 3 (0.4)
114 (7.1)
47 (2.9)
23 (1.4)
18 (1.1)
 6 (0.4)
 4 (0.3)
 4 (0.3)
 4 (0.3)
 8 (0.5)
Renal cell carcinoma
   Conventional
   Papillary
   Chromophobic
   Collecting duct
   Unclassified
776 (90.5)
682 (79.6)
46 (5.4)
39 (4.6)
 1 (0.1)
 8 (0.9)
692 (93.4)
577 (77.9)
51 (6.9)
54 (7.3)
 4 (0.5)
 6 (0.8)
1,468 (91.9)
1,259 (78.8)
97 (6.1)
93 (5.8)
 5 (0.3)
14 (0.9)
Other malignancy  5 (0.6) 11 (1.5) 16 (1.0)
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3.7%, respectively, showing a significant linear-by-linear asso-
ciation on Cochran-Armitage trend test (P < 0.001). Benign le-
sions were more common in cystic lesions than in solid lesions 
(13.6% vs 6.5%, P = 0.002). On multiple logistic regression anal-
ysis, female gender, smaller tumor size, and cystic renal lesions 
were independent predictors of benign histological features 
(Table 3). When 132 cystic renal lesions were classified accord-
ing to their pathologic results, Bosniak category III lesions had 
a 31.8% chance of being benign, while Bosniak category IV le-
sions had only a 4.5% chance of being benign (Table 4).
DISCUSSION
To our knowledge, this study is the largest contemporary series 
to evaluate the incidence of benign renal lesions in Asian pa-
tients. The overall incidence of benign pathological findings in 
Korean patients at surgery was 7.1%, which is lower than the in-
cidences reported in recent studies from Western countries (3, 
6-11). In this respect, it has already been suggested that the low 
incidence of oncocytomas in Asian patients is one reason why 
Asian patients have a lower incidence of benign renal lesions 
compared to Western patients (12). In the present study, AML 
(2.9%) was the most common benign finding, followed by on-
cocytoma (1.4%), which was approximately half as common as 
AML. These results were consistent with the findings of two 
previous studies showing that oncocytoma was less frequent in 
Asian countries in comparison with a 6%-13% incidence in West-
ern countries (12, 13). Notably, the overall incidence of benign 
lesions in our data was slightly lower than the incidence of be-
nign lesions reported in studies from Japan and China (12, 13). 
These differences might be due to different inclusion criteria and 
additional imaging studies. We included renal masses larger 
than 7 cm and excluded a large number of benign cases through 
multimodal preoperative imaging studies. Studies have shown 
that patients with larger tumors have a lower incidence of be-
nign lesions (17). In addition, when there was an obscure lesion 
on a CT image, we did not hesitate to perform additional imag-
ing studies, including another round of CT, MRI, or additional 
contrast-enhanced renal USG, which could improve the char-
acterization of renal tumors (18-21). Therefore, a number of be-
nign lesions, such as AMLs or benign cystic lesions, were exclud-
ed. This may explain why we observed a lower incidence of be-
nign lesions compared with those in other East Asian series. 
Many studies have demonstrated that the incidence of benign 
renal lesions at surgery is higher in female patients (11-13). In 
this respect, our data were consistent. The incidence of benign 
lesions in women was about four times higher than that in men 
(odds ratio [OR] 3.899, 95% confidence interval [CI] 2.62-5.81,  
P < 0.001), which could be attributed to the higher incidence of 
AML in women than in men (6.2% vs 1.4%, P < 0.001). Unlike the 
clear association with sex, however, there is controversy about 
the relationship between tumor size and pathological results. 
Studies have tended to show an inverse relationship between 
tumor size and the incidence of benign lesions on univariate 
analysis (22), although studies that excluded larger renal lesions 
did not show a relationship in multivariate analysis (11, 12, 23). 
By limiting the inclusion criteria to small lesions, the significant 
relationship between tumor size and pathological outcome dis-
appeared. In contrast, studies that included all renal masses 
without size limitations exhibited a significant relationship be-
tween tumor size and pathological outcome (10). In this study, 
the incidence of benign lesions was significantly related to tu-
mor size, similar to results reported by Frank et al. (5), who ana-
lyzed a large cohort of 2,935 tumors. Cystic renal lesions were 
also independently associated with the incidence of benign his-
tological features. The incidence of benign lesions was about 
two times higher in cystic lesions than in solid lesions (OR 2.177, 
95% CI 1.25-3.80, P = 0.006). When cystic renal lesions were clas-
sified according to Bosniak classification, 31.8% of category III 
lesions and 4.5% of category IV lesions were benign. The inci-
dences of benign lesions were slightly lower than those of previ-
ous studies (24, 25). In a comprehensive literature review, War-
ren et al. (26) reported incidences of benign lesions in category 
III and IV lesions of 67% and 7.5%, respectively. However, this 
might also be attributed to more active implementation of addi-
tional imaging studies, such as contrast-enhanced USG, at our 
institution (27). Quaia et al. (28) reported that contrast-enhanced 
USG was better than CT for the diagnosis of malignancy in com-
plex cystic renal masses. In addition, the differences in the defi-
nitions of Bosniak classifications among centers might influence 
the results. To our knowledge, our study is the first to report the 
incidence of benign lesions for presumed RCC in light of specif-
Table 3. Logistic regression analysis of variables that were predictive of benign lesions
Variables Odds ratio (95% CI) P value
Age 0.994 (0.98-1.01)   0.476
Tumor size 0.882 (0.81-0.96) 0.002
Gender
   Male
   Female
 
1.00
3.899 (2.62-5.81)
 
 
< 0.001
Hematuria 
   No
   Yes
 
1.00
0.532 (0.19-1.51)
 
 
0.234
Nature of the lesion 
   Solid
   Cystic
 
1.00
2.177 (1.25-3.80)
 
 
0.006
CI, confidence interval.
Table 4. Pathological findings of all 132 cystic renal lesions
Bosniak category No. of samples
Pathological findings
Benign Malignant
III    44 (33.3) 14 (31.8)   30 (68.2)
IV    88 (66.7) 4 (4.5)   84 (95.5)
Total 132 (100) 18 (13.6) 114 (86.4)Park SY, et al.  •  Incidence and Predictive Factors of Benign Renal Lesions 
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ic presenting symptoms. Interestingly, we found no difference 
between benign and malignant lesions with respect to the fol-
lowing presenting symptoms: ipsilateral flank pain, mass pal-
pability, or systemic symptoms such as weight loss or severe fa-
tigue. Although gross hematuria was more common in malig-
nancy, the significance of this difference disappeared on multi-
variate analysis.
  Our study had some limitations. First, its retrospective nature 
might have skewed our data, although we included a large co-
hort of patients. Second, as a single-center study, there may be 
undetected regional and demographic trends that might have 
influenced the types of patients who came to our institution. 
Third, we used the final pathological tumor diameter instead of 
the radiological tumor diameter. A study conducted by Schlomer 
et al. (29) reported that preoperative CT imaging may slightly 
overestimate the pathological sizes of renal tumors with diame-
ters of 1-5 cm. Therefore, to determine the clinical predictors of 
benign lesions, tumor sizes measured through imaging studies 
would be more reasonable. However, it is also well known that, 
for renal tumors, clinical size and pathological size are highly 
correlated with each other (30). In addition, more than one half 
of all of the study patients were transferred to our institution af-
ter CT or MR imaging was performed at a previous institution. 
Consequently, there were differences in imaging protocols that 
might have caused differences in measurements. Furthermore, 
a considerable time gap intervened between CT scanning and 
nephrectomy, during which time tumor growth might have oc-
curred. For this reason, it was difficult to use radiological tumor 
sizes in this study. Finally, the number of partial nephrectomies 
was significantly higher for benign lesions. However, the reason 
seems to be that benign lesions were smaller. Despite these lim-
itations, the results of this study may provide valuable informa-
tion for clinicians counseling patients with renal lesions and may 
help clinicians decide the most appropriate therapeutic modal-
ity, including renal biopsies and close monitoring.
  In conclusion, a large cohort from a single institution in Korea 
showed a lower incidence (7.1%) of benign renal lesions than 
those found in Western studies. The most common benign le-
sion was AML, which accounted for 41.2% of all benign lesions. 
When a tumor was 4 cm or smaller, AML was the most common 
benign renal tumor, while oncocytoma was the most prevalent 
when the tumor was larger than 4 cm. Female gender, cystic re-
nal lesions, and smaller tumor size were independently associ-
ated with the incidence of benign histological features.
REFERENCES
1. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising inci-
dence of small renal masses: a need to reassess treatment effect. J Natl 
Cancer Inst 2006; 98: 1331-4.
2. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. 
The natural history of incidentally detected small renal masses. Cancer 
2004; 100: 738-45.
3. Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detec-
tion rate of benign renal tumors: evaluation of factors predicting for be-
nign tumor histologic features during past two decades. Urology 2009; 
73: 1293-7.
4. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in 
the adult patient: the role of percutaneous biopsy. Radiology 2006; 240: 
6-22.
5. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid 
renal tumors: an analysis of pathological features related to tumor size. J 
Urol 2003; 170: 2217-20.
6. Kutikov A, Fossett LK, Ramchandani P, Tomaszewski JE, Siegelman ES, 
Banner MP, Van Arsdalen KN, Wein AJ, Malkowicz SB. Incidence of be-
nign pathologic findings at partial nephrectomy for solitary renal mass 
presumed to be renal cell carcinoma on preoperative imaging. Urology 
2006; 68: 737-40.
7. Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight 
CJ, Campbell SC. A preoperative prognostic nomogram for solid enhanc-
ing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 
2007; 178: 429-34.
8. McKiernan J, Yossepowitch O, Kattan MW, Simmons R, Motzer RJ, Reuter 
VE, Russo P. Partial nephrectomy for renal cortical tumors: pathologic 
findings and impact on outcome. Urology 2002; 60: 1003-9.
9. Pahernik S, Roos F, Hampel C, Gillitzer R, Melchior SW, Thüroff JW. 
Nephron sparing surgery for renal cell carcinoma with normal contra-
lateral kidney: 25 years of experience. J Urol 2006; 175: 2027-31.
10. Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB. Pathologi-
cal features of renal neoplasms classified by size and symptomatology. J 
Urol 2006; 176: 1317-20. 
11. Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P. Incidence 
of benign lesions for clinically localized renal masses smaller than 7 cm 
in radiological diameter: influence of sex. J Urol 2006; 176: 2391-5.
12. Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, 
Kumagai J, Kihara K, Fukui I. Incidence of benign pathologic lesions at 
partial nephrectomy for presumed RCC renal masses: Japanese dual-cen-
ter experience with 176 consecutive patients. Urology 2008; 72: 598-602.
13. Xiong YH, Zhang ZL, Li YH, Liu ZW, Hou GL, Liu Q, Yun JP, Zhang XQ, 
Zhou FJ. Benign pathological findings in 303 Chinese patients undergo-
ing surgery for presumed localized renal cell carcinoma. Int J Urol 2010; 
17: 517-21.
14. Bosniak MA. Diagnosis and management of patients with complicated 
cystic lesions of the kidney. AJR Am J Roentgenol 1997; 169: 819-21.
15. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble 
JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, 
Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B. The 
Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3.
16. Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, Darson 
M, Delahunt B, Iczkowski K. Classification of renal cell carcinoma: Work-
group No. 1. Union Internationale Contre le Cancer (UICC) and the Amer-
ican Joint Committee on Cancer (AJCC). Cancer 1997; 80: 987-9.
17. Schachter LR, Cookson MS, Chang SS, Smith JA Jr, Dietrich MS, Jayaram 
G, Herrell SD. Second prize: frequency of benign renal cortical tumors 
and histologic subtypes based on size in a contemporary series: what to 
tell our patients. J Endourol 2007; 21: 819-23.Park SY, et al.  •  Incidence and Predictive Factors of Benign Renal Lesions 
364   http://jkms.org DOI: 10.3346/jkms.2011.26.3.360
18. Hélénon O, André M, Correas JM, Khairoune A, Merran S, Balleyguier 
C. Characterization of renal masses. J Radiol 2002; 83: 787-804.
19. Pallwein L, Mitterberger M, Aigner F, Pinggera GM, Gradl J, Klauser A, 
Halpern EJ, Strasser H, Bartsch G, Frauscher F. Small renal masses: the 
value of contrast-enhanced colour Doppler imaging. BJU Int 2007; 99: 
579-85.
20. Roy C, Gengler L, Sauer B, Lang H. Role of contrast enhanced US in the 
evaluation of renal tumors. J Radiol 2008; 89: 1735-44.
21. Tello R, Davison BD, O’Malley M, Fenlon H, Thomson KR, Witte DJ, 
Harewood L. MR imaging of renal masses interpreted on CT to be suspi-
cious. AJR Am J Roentgenol 2000; 174: 1017-22.
22. Kim SI, Choi YD, Kim SJ, Chung BH, Seong do H, Kim CI, Cheon SH, 
Cho JS, Song YS, Kim YS, Cho IR, Lee DH, Song KH, Kim HS, Lee JS, 
Yang WJ, Hong SJ. A multi-institutional study on histopathological char-
acteristics of surgically treated renal tumors: the importance of tumor 
size. Yonsei Med J 2008; 49: 639-46.
23. Jeon HG, Lee SR, Kim KH, Oh YT, Cho NH, Rha KH, Yang SC, Han WK. 
Benign lesions after partial nephrectomy for presumed renal cell carci-
noma in masses 4 cm or less: prevalence and predictors in Korean pa-
tients. Urology 2010; 76: 574-9.
24. Lang EK, Macchia RJ, Gayle B, Richter F, Watson RA, Thomas R, Myers L. 
CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 
2F): accuracy and impact on clinical management. Eur Radiol 2002; 12: 
2518-24.
25. Marszalek M, Ponholzer A, Brössner C, Wachter J, Maier U, Maders-
bacher S. Elective open nephron-sparing surgery for renal masses: single-
center experience with 129 consecutive patients. Urology 2004; 64: 38-42.
26. Warren KS, McFarlane J. The Bosniak classification of renal cystic masses. 
BJU Int 2005; 95: 939-42.
27. Ascenti G, Mazziotti S, Zimbaro G, Settineri N, Magno C, Melloni D, Ca-
ruso R, Scribano E. Complex cystic renal masses: characterization with 
contrast-enhanced US. Radiology 2007; 243: 158-65.
28. Quaia E, Bertolotto M, Cioffi V, Rossi A, Baratella E, Pizzolato R, Cov MA. 
Comparison of contrast-enhanced sonography with unenhanced sonog-
raphy and contrast-enhanced CT in the diagnosis of malignancy in com-
plex cystic renal masses. AJR Am J Roentgenol 2008; 191: 1239-49.
29. Schlomer B, Figenshau RS, Yan Y, Bhayani SB. How does the radiograph-
ic size of a renal mass compare with the pathologic size? Urology 2006; 
68: 292-5.
30. Yaycioglu O, Rutman MP, Balasubramaniam M, Peters KM, Gonzalez 
JA. Clinical and pathologic tumor size in renal cell carcinoma; difference, 
correlation, and analysis of the influencing factors. Urology 2002; 60: 33-8.
AUTHOR SUMMARY
Incidence and Predictive Factors of Benign Renal Lesions in Korean Patients with 
Preoperative Imaging Diagnoses of Renal Cell Carcinoma 
Seo Yong Park, Seong Soo Jeon, Seo Yeon Lee, Byong Chang Jeong, Seong Il Seo, Hyun Moo Lee, and Han Yong Choi
The incidence of benign renal masses has increased along with the increasing incidence of renal cell carcinoma because current 
imaging and biopsy techniques cannot predict the histological features of renal tumors with complete accuracy. In contemporary 
practice, a number of Western studies have reported a 13%-25% incidence of benign renal lesions at nephrectomy, although data 
on Asian patients are scarce. Hence, the present study was performed to determine the incidence and predictive factors of benign 
renal lesions in Korean patients undergoing nephrectomy for presumed renal cell carcinoma on preoperative imaging. The overall 
incidence of benign pathological findings in Korean patients at surgery was 7.1%, which is lower than the incidences reported in 
recent studies from Western countries. Female gender, smaller tumor size, and cystic lesions were significantly associated with 
benign histological features.